SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-21-000641
Filing Date
2021-12-22
Accepted
2021-12-22 14:48:09
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-K rgbp093021form10k.htm   iXBRL 10-K 2987154
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9503
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9482
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4229
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4100
  Complete submission text file 0001607062-21-000641.txt   7603483

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rgbp-20210930.xsd EX-101.SCH 59512
7 XBRL CALCULATION FILE rgbp-20210930_cal.xml EX-101.CAL 49959
8 XBRL DEFINITION FILE rgbp-20210930_def.xml EX-101.DEF 180100
9 XBRL LABEL FILE rgbp-20210930_lab.xml EX-101.LAB 311844
10 XBRL PRESENTATION FILE rgbp-20210930_pre.xml EX-101.PRE 255936
55 EXTRACTED XBRL INSTANCE DOCUMENT rgbp093021form10k_htm.xml XML 1037324
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191725 | Film No.: 211512825
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences